Epitope identification from fixed-complexity random-sequence peptide microarrays.
Identifieur interne : 001798 ( PubMed/Curation ); précédent : 001797; suivant : 001799Epitope identification from fixed-complexity random-sequence peptide microarrays.
Auteurs : Josh Richer [États-Unis] ; Stephen Albert Johnston [États-Unis] ; Phillip Stafford [États-Unis]Source :
- Molecular & cellular proteomics : MCP [ 1535-9484 ] ; 2015.
Descripteurs français
- KwdFr :
- Algorithmes, Analyse par réseau de protéines, Anticorps monoclonaux (), Cartographie peptidique (), Cartographie épitopique (), Coqueluche (immunologie), Dengue (immunologie), Humains, Hépatite B (immunologie), Maladie de Lyme (immunologie), Paludisme (immunologie), Peptides (), Syphilis (immunologie), Séquence d'acides aminés, Épitopes ().
- MESH :
English descriptors
- KwdEn :
- Algorithms, Amino Acid Sequence, Antibodies, Monoclonal (chemistry), Dengue (immunology), Epitope Mapping (methods), Epitopes (chemistry), Hepatitis B (immunology), Humans, Lyme Disease (immunology), Malaria (immunology), Peptide Mapping (methods), Peptides (chemistry), Protein Array Analysis, Syphilis (immunology), Whooping Cough (immunology).
- MESH :
- chemical , chemistry : Antibodies, Monoclonal, Epitopes, Peptides.
- immunology : Dengue, Hepatitis B, Lyme Disease, Malaria, Syphilis, Whooping Cough.
- methods : Epitope Mapping, Peptide Mapping.
- Algorithms, Amino Acid Sequence, Humans, Protein Array Analysis.
Abstract
Antibodies play an important role in modern science and medicine. They are essential in many biological assays and have emerged as an important class of therapeutics. Unfortunately, current methods for mapping antibody epitopes require costly synthesis or enrichment steps, and no low-cost universal platform exists. In order to address this, we tested a random-sequence peptide microarray consisting of over 330,000 unique peptide sequences sampling 83% of all possible tetramers and 27% of pentamers. It is a single, unbiased platform that can be used in many different types of tests, it does not rely on informatic selection of peptides for a particular proteome, and it does not require iterative rounds of selection. In order to optimize the platform, we developed an algorithm that considers the significance of k-length peptide subsequences (k-mers) within selected peptides that come from the microarray. We tested eight monoclonal antibodies and seven infectious disease cohorts. The method correctly identified five of the eight monoclonal epitopes and identified both reported and unreported epitope candidates in the infectious disease cohorts. This algorithm could greatly enhance the utility of random-sequence peptide microarrays by enabling rapid epitope mapping and antigen identification.
DOI: 10.1074/mcp.M114.043513
PubMed: 25368412
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001798
Links to Exploration step
pubmed:25368412Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Epitope identification from fixed-complexity random-sequence peptide microarrays.</title>
<author><name sortKey="Richer, Josh" sort="Richer, Josh" uniqKey="Richer J" first="Josh" last="Richer">Josh Richer</name>
<affiliation wicri:level="2"><nlm:affiliation>From *Arizona State University, Tempe, Arizona 85287.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
<wicri:cityArea>From *Arizona State University, Tempe</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Johnston, Stephen Albert" sort="Johnston, Stephen Albert" uniqKey="Johnston S" first="Stephen Albert" last="Johnston">Stephen Albert Johnston</name>
<affiliation wicri:level="2"><nlm:affiliation>From *Arizona State University, Tempe, Arizona 85287.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
<wicri:cityArea>From *Arizona State University, Tempe</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Stafford, Phillip" sort="Stafford, Phillip" uniqKey="Stafford P" first="Phillip" last="Stafford">Phillip Stafford</name>
<affiliation wicri:level="1"><nlm:affiliation>From *Arizona State University, Tempe, Arizona 85287 phillip.stafford@asu.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>From *Arizona State University, Tempe</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25368412</idno>
<idno type="pmid">25368412</idno>
<idno type="doi">10.1074/mcp.M114.043513</idno>
<idno type="wicri:Area/PubMed/Corpus">001798</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001798</idno>
<idno type="wicri:Area/PubMed/Curation">001798</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001798</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Epitope identification from fixed-complexity random-sequence peptide microarrays.</title>
<author><name sortKey="Richer, Josh" sort="Richer, Josh" uniqKey="Richer J" first="Josh" last="Richer">Josh Richer</name>
<affiliation wicri:level="2"><nlm:affiliation>From *Arizona State University, Tempe, Arizona 85287.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
<wicri:cityArea>From *Arizona State University, Tempe</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Johnston, Stephen Albert" sort="Johnston, Stephen Albert" uniqKey="Johnston S" first="Stephen Albert" last="Johnston">Stephen Albert Johnston</name>
<affiliation wicri:level="2"><nlm:affiliation>From *Arizona State University, Tempe, Arizona 85287.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
<wicri:cityArea>From *Arizona State University, Tempe</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Stafford, Phillip" sort="Stafford, Phillip" uniqKey="Stafford P" first="Phillip" last="Stafford">Phillip Stafford</name>
<affiliation wicri:level="1"><nlm:affiliation>From *Arizona State University, Tempe, Arizona 85287 phillip.stafford@asu.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>From *Arizona State University, Tempe</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Molecular & cellular proteomics : MCP</title>
<idno type="eISSN">1535-9484</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Algorithms</term>
<term>Amino Acid Sequence</term>
<term>Antibodies, Monoclonal (chemistry)</term>
<term>Dengue (immunology)</term>
<term>Epitope Mapping (methods)</term>
<term>Epitopes (chemistry)</term>
<term>Hepatitis B (immunology)</term>
<term>Humans</term>
<term>Lyme Disease (immunology)</term>
<term>Malaria (immunology)</term>
<term>Peptide Mapping (methods)</term>
<term>Peptides (chemistry)</term>
<term>Protein Array Analysis</term>
<term>Syphilis (immunology)</term>
<term>Whooping Cough (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Algorithmes</term>
<term>Analyse par réseau de protéines</term>
<term>Anticorps monoclonaux ()</term>
<term>Cartographie peptidique ()</term>
<term>Cartographie épitopique ()</term>
<term>Coqueluche (immunologie)</term>
<term>Dengue (immunologie)</term>
<term>Humains</term>
<term>Hépatite B (immunologie)</term>
<term>Maladie de Lyme (immunologie)</term>
<term>Paludisme (immunologie)</term>
<term>Peptides ()</term>
<term>Syphilis (immunologie)</term>
<term>Séquence d'acides aminés</term>
<term>Épitopes ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antibodies, Monoclonal</term>
<term>Epitopes</term>
<term>Peptides</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Coqueluche</term>
<term>Dengue</term>
<term>Hépatite B</term>
<term>Maladie de Lyme</term>
<term>Paludisme</term>
<term>Syphilis</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Dengue</term>
<term>Hepatitis B</term>
<term>Lyme Disease</term>
<term>Malaria</term>
<term>Syphilis</term>
<term>Whooping Cough</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Epitope Mapping</term>
<term>Peptide Mapping</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Algorithms</term>
<term>Amino Acid Sequence</term>
<term>Humans</term>
<term>Protein Array Analysis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Algorithmes</term>
<term>Analyse par réseau de protéines</term>
<term>Anticorps monoclonaux</term>
<term>Cartographie peptidique</term>
<term>Cartographie épitopique</term>
<term>Humains</term>
<term>Peptides</term>
<term>Séquence d'acides aminés</term>
<term>Épitopes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Antibodies play an important role in modern science and medicine. They are essential in many biological assays and have emerged as an important class of therapeutics. Unfortunately, current methods for mapping antibody epitopes require costly synthesis or enrichment steps, and no low-cost universal platform exists. In order to address this, we tested a random-sequence peptide microarray consisting of over 330,000 unique peptide sequences sampling 83% of all possible tetramers and 27% of pentamers. It is a single, unbiased platform that can be used in many different types of tests, it does not rely on informatic selection of peptides for a particular proteome, and it does not require iterative rounds of selection. In order to optimize the platform, we developed an algorithm that considers the significance of k-length peptide subsequences (k-mers) within selected peptides that come from the microarray. We tested eight monoclonal antibodies and seven infectious disease cohorts. The method correctly identified five of the eight monoclonal epitopes and identified both reported and unreported epitope candidates in the infectious disease cohorts. This algorithm could greatly enhance the utility of random-sequence peptide microarrays by enabling rapid epitope mapping and antigen identification. </div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25368412</PMID>
<DateCompleted><Year>2015</Year>
<Month>09</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1535-9484</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>14</Volume>
<Issue>1</Issue>
<PubDate><Year>2015</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Molecular & cellular proteomics : MCP</Title>
<ISOAbbreviation>Mol. Cell Proteomics</ISOAbbreviation>
</Journal>
<ArticleTitle>Epitope identification from fixed-complexity random-sequence peptide microarrays.</ArticleTitle>
<Pagination><MedlinePgn>136-47</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/mcp.M114.043513</ELocationID>
<Abstract><AbstractText>Antibodies play an important role in modern science and medicine. They are essential in many biological assays and have emerged as an important class of therapeutics. Unfortunately, current methods for mapping antibody epitopes require costly synthesis or enrichment steps, and no low-cost universal platform exists. In order to address this, we tested a random-sequence peptide microarray consisting of over 330,000 unique peptide sequences sampling 83% of all possible tetramers and 27% of pentamers. It is a single, unbiased platform that can be used in many different types of tests, it does not rely on informatic selection of peptides for a particular proteome, and it does not require iterative rounds of selection. In order to optimize the platform, we developed an algorithm that considers the significance of k-length peptide subsequences (k-mers) within selected peptides that come from the microarray. We tested eight monoclonal antibodies and seven infectious disease cohorts. The method correctly identified five of the eight monoclonal epitopes and identified both reported and unreported epitope candidates in the infectious disease cohorts. This algorithm could greatly enhance the utility of random-sequence peptide microarrays by enabling rapid epitope mapping and antigen identification. </AbstractText>
<CopyrightInformation>© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Richer</LastName>
<ForeName>Josh</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>From *Arizona State University, Tempe, Arizona 85287.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Johnston</LastName>
<ForeName>Stephen Albert</ForeName>
<Initials>SA</Initials>
<AffiliationInfo><Affiliation>From *Arizona State University, Tempe, Arizona 85287.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stafford</LastName>
<ForeName>Phillip</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>From *Arizona State University, Tempe, Arizona 85287 phillip.stafford@asu.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mol Cell Proteomics</MedlineTA>
<NlmUniqueID>101125647</NlmUniqueID>
<ISSNLinking>1535-9476</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000939">Epitopes</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018604" MajorTopicYN="N">Epitope Mapping</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008193" MajorTopicYN="N">Lyme Disease</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008288" MajorTopicYN="N">Malaria</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010449" MajorTopicYN="N">Peptide Mapping</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D040081" MajorTopicYN="N">Protein Array Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013587" MajorTopicYN="N">Syphilis</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014917" MajorTopicYN="N">Whooping Cough</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>11</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>11</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>9</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25368412</ArticleId>
<ArticleId IdType="pii">M114.043513</ArticleId>
<ArticleId IdType="doi">10.1074/mcp.M114.043513</ArticleId>
<ArticleId IdType="pmc">PMC4288249</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>FEBS Lett. 2002 Feb 20;513(1):107-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11911888</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Commun. 2014;5:4785</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25183057</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2002 Oct 3;419(6906):498-511</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12368864</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Drug Targets. 2004 Jan;5(1):1-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14738215</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods Mol Biol. 2004;248:443-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14970513</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Parasite Immunol. 1986 Nov;8(6):529-39</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3543808</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO J. 1995 Jun 15;14(12):2715-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7796800</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Trop Med Hyg. 1997 Apr;56(4):466-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9158059</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol Methods. 1997 Aug 7;206(1-2):43-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9328567</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Comb Chem High Throughput Screen. 1999 Jun;2(3):125-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10420967</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Appl Microbiol Biotechnol. 2006 Mar;70(1):2-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16365766</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proteomics. 2006 Aug;6(15):4210-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16819727</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Drug Discov. 2007 May;6(5):349-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17431406</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Biochem Cell Biol. 2009 Jul;41(7):1463-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19150410</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2010 Mar 15;398(2):290-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20079511</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2010 Jun 17;28(28):4529-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20450869</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Proteomics. 2011 Mar;10(3):M110.000786</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21062935</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bioinformatics. 2011 Apr 1;27(7):899-902</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21300698</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Neurol. 2011 Aug;70(2):286-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21823156</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Rep. 2012;2:267</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22355779</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Vaccine Immunol. 2012 Apr;19(4):527-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22336289</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Proteomics. 2012 Apr;11(4):M111.011593</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22261726</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Immunol. 2012 Jul;51(3-4):304-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22520973</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(7):e40201</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22815729</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Proteomics. 2012 Dec;11(12):1790-800</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22984286</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neuroimmunol. 2013 Jan 15;254(1-2):154-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23084373</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Biotechnol. 2013 Jan;31(1):45-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23219199</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2013;8(7):e68902</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23894373</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19330-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24222690</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Proteomics. 2014 Jun;13(6):1585-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24705123</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Proteomics. 2014 Jun;13(6):1611-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24722731</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Immunol. 2014;15:23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24908187</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):E3072-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25024171</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Vaccine Immunol. 2014 Aug;21(8):1169-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24964807</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2002 Oct 4;322(5):1039-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12367527</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001798 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001798 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:25368412 |texte= Epitope identification from fixed-complexity random-sequence peptide microarrays. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25368412" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |